Video

Education and Teamwork Are Key in the Treatment of MPNs

At the 2019 MPN Heroes® event Tammy Matuska, B.S.N., RN, known as the "lifeline to patients," was honored for her outstanding work for patients with MPN.

One of the nine honorees at the 2019 MPN Heroes® event, Tammy Matuska, B.S.N., RN, is known as “a lifeline to patients.” While she spends her days as a nurse coordinator at the Washington University School of Medicine in St. Louis, Missouri, Matuska strives to find new treatments and provide education, emotional aid and care for patients with a rare group of blood cancers known as myeloproliferative neoplasms, or MPNs: polycythemia vera, essential thrombocythemia, and myelofibrosis.

In addition to helping her patients with scheduling and paperwork, Matuska works after hours to ensure that her patients have access to proper care. She’s even spearheaded the organization of an informational dinner for patients and their families and is in the process of creating a support group for people with MPNs.

In an interview at CURE® magazine’s seventh annual event on Dec. 6 in Orlando, Florida, Matuska explained why education and teamwork are key to caring for those in the MPN community.

“I’m part of a team. It takes a lot of people to take care of these patients. We have research coordinators, clinic nurse coordinators, lab researchers; we all work as a team together on a cure for these MPNs and to take care of these patients,” Matuska said.

“Our community is very small. I like to raise awareness with other individuals that I work with, peers that don’t know what an MPN is. I’m constantly getting that: “What’s an MPN?”, so I love to educate other coworkers and also patients and family members on what MPNs are.”

Newsletter

Stay up to date on cancer updates, research and education

Related Videos
Daniel Jernazian, who beat cancer twice, credits his sports mindset for survival and calls it winning his ‘life World Championship’.
Patients in rural or underserved areas may have worse outcomes, highlighting the need for early support to address care access barriers.
Image of man with text.
Dr. Emre Yekedüz discusses how ASCO 2025 highlights precision medicine, biomarkers and the gut microbiome as keys to advancing kidney cancer care.
Dr. Breelyn Wilky stresses the importance of expert guidance and second opinions for patients with GIST, as treatment options continue to evolve rapidly.
Mark Daniels, 83, credits CAR T-cell therapy and compassionate care for helping him overcome lymphoma and endure the isolating treatment toll.
An early study of BGB-16673 for hard-to-treat leukemia found that side effects were manageable with no new safety concerns.
Image of woman with text.
Image of goy, and text.
Watch oncology dietitian Kenisha Parikh prepare creamy lentil soup, a soothing, protein-packed recipe to help ease side effects during treatment.
Related Content